Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety

NCT00177008 is registered in ClinicalTrials.gov with University of Medicine and Dentistry of New Jersey as lead sponsor.

NCT NCT00177008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00177008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety
Lead sponsor
University of Medicine and Dentistry of New Jersey
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2004
Completion date
January 31, 2007
Enrollment
18
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia, social anxiety disorder